SEARCH

SEARCH BY CITATION

References

  • Abdel Rassoul, R., Alves, S., Pantesco, V., De Vos, J., Michel, B., Perret, M., Mestre-Francés, N., Verdier, J.M. & Devau, G. (2010) Distinct transcriptome expression of the temporal cortex of the primate microcebus murinus during brain aging versus Alzheimer's disease-like pathology. PLoS One 5, pii: e12770.
  • Barbier, E. & Wang, J.B. (2009) Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci 10, 132.
  • Barbier, E., Zapata, A., Oh, E., Liu, Q., Zhu, F., Undie, A., Shippenberg, T. & Wang, J.B. (2007) Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology 32, 17741782.
  • Biala, G. & Budzynska, B. (2006) Effects of acute and chronic nicotine on elevated plus maze in mice: involvement of calcium channels. Life Sci 79, 8188.
  • Chen, Q., Wang, X., O'Neill, F.A., Walsh, D., Kendler, K.S. & Chen, X. (2008) Is the histidine triad nucleotide-binding protein (HINT1) gene a candidate for schizophrenia? Schizophr Res 106, 200207.
  • Collins, A.C., Miner, L.L. & Marks, M.J. (1988) Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol Biochem Behav 30, 269278.
  • D'Amour, F.E. & Smith, D.L. (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72, 7479.
  • Dennis, S.G., Melzack, R., Gutman, S. & Boucher, F. (1980) Pain modulation by adrenergic agents and morphine as measured by three pain tests. Life Sci 26, 12471259.
  • Elashoff, M., Higgs, B.W., Yolken, R.H., Knable, M.B., Weis, S., Webster, M.J., Barci, B.M. & Torrey, E.F. (2007) Meta-analysis of 12 genomic studies in bipolar disorder. J Mol Neurosci 31, 221244.
  • Guang, W., Wang, H., Su, T., Weinstein, I.B. & Wang, J.B. (2004) Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol Pharmacol 66, 12851292.
  • Jackson, K.J., Martin, B.R., Changeux, J.P. & Damaj, M.I. (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325, 302312.
  • Jackson, K.J., Kota, D.H., Martin, B.R. & Damaj, M.I. (2009) The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology 56, 970974.
  • Jackson, K.J., Marks, M.J., Vann, R.E., Chen, X., Gamage, T.F., Warner, J.A. & Damaj, M.I. (2010) The role of α5 nicotinic acetylcholine receptors in the behavioral and pharmacological effects of nicotine in mice. J Pharmacol Exp Ther 334, 137146.
  • Jackson, K.J., Chen, Q., Chen, J., Aggen, S.H., Kendler, K.S. & Chen, X. (2011) Association of histidine-triad nucleotide binding protein 1 (HINT1) gene variants with nicotine dependence. Pharmacogenomics J 11, 251257.
  • King, T.E., Joynes, R.L. & Grau, J.W. (1997) Tail-flick test II. The role of supraspinal systems and avoidance learning. Behav Neurosci 111, 754767.
  • Konradi, C. (2005) Gene expression microarray studies in polygenic disorders: applications and data analysis. Brain Res Brain Res Rev 50, 142155.
  • Kurotaki, N., Tasaki, S., Mishima, H., Ono, S., Imamura, A., Kikuchi, T., Nishida, N., Tokunaga, K., Yoshiura, K. & Ozawa, H. (2011) Identification of novel schizophrenia loci by homozygosity mapping using DNA microarray analysis. PLoS One 6, e20589. DOI:10.1371/journal.pone.0020589.
  • Lewis, D.A. & Lieberman, J.A. (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325334.
  • Li, H., Zhang, Y., Su, T., Santella, R.M. & Weinstein, I.B. (2006) Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 25, 713721.
  • Liu, Q., Puche, A.C. & Wang, J.B. (2008) Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem Res 33, 12631276.
  • Marubio, L.M., del Mar Arroyo-Jimenez, M., Cordero-Erausquin, M., Léna, C., Le Novère, N., de Kerchove d'Exaerde, A., Huchet, M., Damaj, M.I. & Changeux, J.P. (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398, 805810.
  • O'Neill, A.B. & Brioni, J.D. (1994) Benzodiazepine receptor mediation of the anxiolytic-like effect of (−)-nicotine in mice. Pharmacol Biochem Behav 49, 755757.
  • Picciotto, M.R., Zoli, M., Rimondini, R., Léna, C., Marubio, L.M., Pich, E.M., Fuxe, K. & Changeux, J.P. (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173177.
  • Ramabadran, K. & Bansinath, M. (1986) A critical analysis of the experimental evaluation of nociceptine reactions in animals. Pharm Res 3, 263270.
  • Seeman, P. (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1, 133152.
  • Su, T., Suzui, M., Wang, L., Lin, C.S., Xing, W.Q. & Weinstein, I.B. (2003) Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc Natl Acad Sci U S A 100, 78247829.
  • Tallarida, R.J. & Murray, R.B. (1987). Manual of Pharmacological Calculations with Computer Programs. Springer, New York, pp. 29.
  • Varadarajulu, J., Lebar, M., Krishnamoorthy, G., Habelt, S., Lu, J., Bernard Weinstein, I., Li, H., Holsboer, F., Turck, C.W. & Touma, C. (2011) Increased anxiety-related behaviour in Hint1 knockout mice. Behav Brain Res 220, 305311.
  • Varadarajulu, J., Schmitt, A., Falkai, P., Alsaif, M., Turck, C.W. & Martins-de-Souza, D. (2012) Differential expression of HINT1 in schizophrenia brain tissue. Eur Arch Psychiatry Clin Neurosci 262, 167172.
  • Varani, A.P. & Balerio, G.N. (2012) GABA(B) receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice. Pharmacol Res 65, 507513.
  • Vawter, M.P., Barrett, T., Cheadle, C., Sokolov, B.P., Wood, W.H.I.I.I., Donovan, D.M., Webster, M., Freed, W.J. & Becker, K.G. (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55, 641650.
  • Vawter, M.P., Crook, J.M., Hyde, T.M., Kleinman, J.E., Weinberger, D.R., Becker, K.G. & Freed, W.J. (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 58, 1120.
  • Vawter, M.P., Shannon, W.C., Ferran, E., Matsumoto, M., Overman, K., Hyde, T.M., Weinberger, D.R., Bunney, W.E. & Kleinman, J.E. (2004) Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 29, 12451255.
  • Walters, C.L., Brown, S., Changeux, J.P., Martin, B. & Damaj, M.I. (2006) The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 184, 339344.